Scott Colton/bcu.ac.uk and Andy Powell/LinkedIn
Jun 4, 2026, 16:14
Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
Scott Colton, Senior Lecturer at Birmingham City University, shared a post on LinkedIn:
“I’m pleased to share my latest article, which I wrote with Andy Powell published in Nursing Standard Student:
Do you know your anticoagulant from your antiplatelet medications?
In this piece, we explore the key differences between anticoagulant and antiplatelet medications and why the term “blood thinners” is misleading.
We break down the key distinctions between anticoagulant and antiplatelet medications, including how they act, linking them to common clinical presentations such as acute coronary syndrome and deep vein thrombosis.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH